MMSIMMSIHealthcare · Medical Instruments & Supplies

MMSI Stock Forecast: Merit Medical Systems, Inc. Price Predictions for 2026-2027

Last close, 20 Nov 2026
$84
−0.08% on the day

The 12 Wall Street analysts covering Merit Medical Systems, Inc. hold a median 12-month price target of $108 — +27.5% from the last close. Ticker Nerd's systematic factor model, run across ~4,300 US stocks, ranks it 86 of 100 as at 21 Nov 2026 — inside the top quartile. Here, the model and the Street point the same way.

Market cap
$5.1B
Ticker Nerd rank
86/ 100
Median analyst target
$108
Analysts covering
12
Revenue$418.8M+9.5% y/y
Operating income$60.5M
Net income$38.8M
Free cash flow$51.1M
Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
−2.6%
1M
−7.5%
YTD
−4.3%
1Y
−0.6%
From 52W high
−10.5%
From 52W low
+39.8%
$60
$94
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

One number for the whole business

Consensus tells you what everyone already believes. The model scores Merit Medical Systems, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 21 Nov 2026
86/ 100

Percentile across ~4,300 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Volatility
90
Quality
87
Revisions
78
Growth
78
Value
78
Momentum
70
Issuance
50
Accruals
43

Volatility (90): The share price has been relatively steady.

Accruals (43): A large share of reported profit has not shown up as cash, or the balance sheet is expanding quickly — both tend to unwind.

Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.

Wall Street

MMSI stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on MMSI, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$60$80$100$120Jan 26Apr 26Jul 26Oct 26MMSIHigh $123Median $108Low $90

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says12 analysts
9
Buy
3
Hold
0
Sell
$90
Low
$108
Median
$123
High

The green dot is the last close — the median target sits +27.5% from it.

Recent analyst actionsNewest first

Of the 20 most recent actions, 12 moved their price target up and 3 moved it down.

DateFirmActionRatingTarget
12 Nov 2026Freedom Capital MarketsMaintainsHold$90
31 Oct 2026Canaccord GenuityMaintainsBuy—
30 Oct 2026BTIGMaintainsBuy$105 → $110
30 Oct 2026Canaccord GenuityMaintainsBuy$94 → $121
30 Oct 2026JP MorganMaintainsOverweight$95 → $110
30 Oct 2026NeedhamMaintainsBuy$101 → $106
30 Oct 2026Wells FargoMaintainsEqual-Weight$83 → $92
27 Oct 2026Freedom Capital MarketsInitiatesHold$90
29 Sept 2026NeedhamReiteratesBuy$101
13 Aug 2026B of A SecuritiesMaintainsNeutral$92 → $97
11 Aug 2026BTIGReiteratesBuy$105
3 Aug 2026Canaccord GenuityMaintainsBuy$85 → $94
31 July 2026BTIGMaintainsBuy$100 → $105
31 July 2026JP MorganMaintainsOverweight$77 → $95
31 July 2026NeedhamMaintainsBuy$90 → $101
31 July 2026Piper SandlerMaintainsOverweight$96 → $106
31 July 2026Wells FargoMaintainsEqual-Weight$74 → $83
1 May 2026Canaccord GenuityMaintainsBuy$90 → $85
1 May 2026JP MorganMaintainsOverweight$95 → $77
1 May 2026NeedhamMaintainsBuy$101 → $90

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Wall Street targets run 12 to 18 months out. No analyst publishes a 2030 price target for MMSI.

Market Radar

This page is one stock. Monday covers all of them.

MMSI appears in the Radar on the weeks it earns a place.

  • Market Radar, every Monday: the week's biggest rank moves across ~4,300 US stocks, and the reason for each.
  • The AI build-out map, free: every AI company we track on one page, with the model's Top picks in all four parts.

Free. Unsubscribe any time. Privacy

The AI build-out map
PDF
  • AI cloud capacity

    MSFTAMZNGOOGLORCL

  • AI chips

    NVDAAVGOAMDMU

  • AI networking and servers

    ANETDELLLITECRDO

  • Data centre power

    VRTCEGGEVVST

Performance

MMSI vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 20 Nov 2026, Merit Medical Systems, Inc. returned −0.6% against +6.9% for the S&P 500, dividends included.

MMSI vs S&P 500, last 12 monthsTotal return, rebased to 100
708090100110120Jan 26Apr 26Jul 26Oct 26MMSIS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

MMSI analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingThis fiscal year
EPS revision, 90 days
+1.2%
Analysts raising
7
Analysts cutting
0
Fundamentals

Financials

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
31.6×

Cheaper than 27% of US stocks

Price / sales
3.1×

Cheaper than 35% of US stocks

Price / book
2.9×

Cheaper than 32% of US stocks

EV / EBITDA
15.4×

Cheaper than 32% of US stocks

Growth & margins
Revenue growth (YoY)
8.4%

Higher than 50% of US stocks

Earnings growth (YoY)
52.4%

Higher than 76% of US stocks

Gross margin
51.4%

Higher than 63% of US stocks

Operating margin
13.9%

Higher than 71% of US stocks

Net margin
9.9%

Higher than 67% of US stocks

Returns & dividend
Return on equity
9.8%

Higher than 62% of US stocks

Return on assets
5.0%

Higher than 76% of US stocks

Dividend yield
—

Bars mark the percentile across the ~4,300 US stocks Ticker Nerd covers, among those reporting the figure.

Statistics

Key statistics

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • Merit Medical Systems, Inc. has a market value of $5.1B and an enterprise value of $5.4B.

  • Revenue in the twelve months to 30 June 2026: $1.6B. The latest quarter grew 9.5% year on year.

  • Net income over the same four quarters: $145.6M, a 9.2% net margin.

  • Diluted earnings per share, trailing twelve months: $2.42.

  • Free cash flow in the twelve months to 30 June 2026: $199.8M, after $83.7M of capital spending.

  • Shares outstanding: 59.7M.

  • Trailing P/E: 31.6×; forward P/E: 18.1× — the forward figure prices analyst consensus estimates, not reported earnings.

  • Merit Medical Systems, Inc. employs 7,500 people — $211K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 21 Nov 2026

Data provided by Twelve Data

Peers

MMSI and its peers

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelMedical Instruments & Supplies
CompanyMarket capTKN rank
MMSIMerit Medical Systems, Inc.$5.1B86
MMEDMiniMed Group, Inc.$4.5B1
STVNStevanato Group SpA$4.3B59
ICUIICU Medical, Inc.$4.3B95
TFXTeleflex, Inc.$6.4B93
NVSTEnvista Holdings Corp.$3.7B96
BLCOBausch + Lomb Corp.$6.9B99

Take a look at MMSI’s peer groups, ranked by the model: healthcare stocks.

Look up any of the roughly 4,300 stocks we score.

The rank is the raw material. Whether the rules would actually own Merit Medical Systems, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

FAQ

Questions about MMSI

What is the MMSI stock price forecast for 2026-2027?

The 12 Wall Street analysts covering Merit Medical Systems, Inc. have a median 12-month price target of $108, with estimates ranging from $90 to $123. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is MMSI stock a buy right now?

Of the 12 analysts covering Merit Medical Systems, Inc., 9 rate it a Buy, 3 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Merit Medical Systems, Inc. 86 out of 100 across roughly 4,300 US stocks as at 21 Nov 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank MMSI?

As at 21 Nov 2026, Merit Medical Systems, Inc. ranks 86 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,300 US stocks, built from its factor families. Its strongest factor family is Volatility (90 of 100).

Will MMSI stock go up?

No one can know that. What the data says: the median 12-month target from 12 analysts implies +27.5% from the last close, and Ticker Nerd's factor model ranks Merit Medical Systems, Inc. 86 out of 100 as at 21 Nov 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the MMSI stock forecast for 2030?

No analyst covering Merit Medical Systems, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for MMSI are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $90 to $123 over the next 12 months.

How has MMSI stock performed over the past year?

Merit Medical Systems, Inc. returned -0.6% over the 12 months to 20 Nov 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Merit Medical Systems, Inc. do?

Merit Medical Systems, Inc. is a medical device company that develops, manufactures, and markets disposable products used in interventional, diagnostic, and therapeutic procedures. Merit Medical Systems, Inc. serves a wide range of clinical specialties through its Cardiovascular and Endoscopy segments, with offerings that support cardiology, radiology, oncology, critical care, gastroenterology, pulmonology, and thoracic surgery.

Company

About Merit Medical Systems, Inc.

Merit Medical Systems, Inc. is a medical device company that develops, manufactures, and markets disposable products used in interventional, diagnostic, and therapeutic procedures. Merit Medical Systems, Inc. serves a wide range of clinical specialties through its Cardiovascular and Endoscopy segments, with offerings that support cardiology, radiology, oncology, critical care, gastroenterology, pulmonology, and thoracic surgery. Its product portfolio includes access devices, drainage and embolotherapy tools, guide wires, balloon dilators, inflation devices, procedure kits, hemostasis solutions, and other single-use technologies designed for minimally invasive care. The company also provides products used in interventional oncology, spine procedures, cardiac rhythm management, electrophysiology, and cardiovascular critical care. Headquartered in South Jordan, Utah, Merit Medical Systems, Inc. plays a role in supplying hospitals, clinicians, and procedure centers with specialized tools for modern medical interventions.

CEO Ms. Martha Goldberg Aronson · 7,500 employees · United States · https://www.merit.com